The natural history of vascular and other complications in patients treated with nilotinib for chronic myeloid leukemia.
Minson AG, Cummins K, Fox L, Costello B, Yeung D, Cleary R, Forsyth C, Tatarczuch M, Burbury K, Motorna O, Shortt J, Fleming S, McQuillan A, Schwarer A, Harrup R, Holmes A, Ratnasingam S, Chan KL, Hsu WH, Ashraf A, Putt F, Grigg A.
Minson AG, et al. Among authors: tatarczuch m.
Blood Adv. 2019 Apr 9;3(7):1084-1091. doi: 10.1182/bloodadvances.2018028035.
Blood Adv. 2019.
PMID: 30944100
Free PMC article.